drugset / Trial / NCT03183219

Safety and Efficiency of γδ T Cell Against Liver Cancer

NCT03183219

RandomizedParallel-groupSingle-blindTreatment

Summary

In this study, effects of γδT cells on human Liver Cancer in combination with tumor reducing surgery, for example, cryosurgery going to be investigated.

Timeline

Start
2017-06-15
Primary completion
2018-01-15
Completion
2019-06-15

Drugs

EvaluationDrugModalityDoseRoute
Subject γδ T cell Cell therapy

Indications